In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 22 pages - $500
Sep 2010 - 27 pages - $2,000
Mar 2011 - 28 pages - $500
Nov 2010 - 178 pages - $1,495
May 2011 - 15 pages - $250
Sep 2009 - 394 pages - $4,000
Jun 2009 - $15,200
Jun 2010 - 210 pages - $2,500
Nov 2010 - 160 pages - $1,495
Dec 2010 - 29 pages - $1,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us